nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study
|
Davidson, J. A. |
|
2006 |
|
2 |
p. 164-174 |
artikel |
2 |
Association between antipsychotic drugs and diabetes
|
Holt, Richard I. G. |
|
2006 |
|
2 |
p. 125-135 |
artikel |
3 |
A triumph for physiology driving drug discovery: the potential impact of dipeptidyl peptidase-IV inhibitors in type 2 diabetes
|
|
|
2007 |
|
2 |
p. 151-152 |
artikel |
4 |
Differential effect of glimepiride and rosiglitazone on metabolic control of type 2 diabetic patients treated with metformin: a randomized, double-blind, clinical trial
|
Derosa, G. |
|
2006 |
|
2 |
p. 197-205 |
artikel |
5 |
Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug
|
Idris, Iskandar |
|
2007 |
|
2 |
p. 153-165 |
artikel |
6 |
Does ethnic origin have an independent impact on hypertension and diabetic complications?
|
Baskar, V. |
|
2006 |
|
2 |
p. 214-219 |
artikel |
7 |
Double-blind, randomized, multicentre study of the efficacy and safety of gliclazide-modified release in the treatment of Chinese type 2 diabetic patients
|
Lu, C.-H. |
|
2006 |
|
2 |
p. 184-191 |
artikel |
8 |
Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and β-cell function in patients with type 2 diabetes
|
Brazg, R. |
|
2007 |
|
2 |
p. 186-193 |
artikel |
9 |
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
|
Nauck, M. A. |
|
2007 |
|
2 |
p. 194-205 |
artikel |
10 |
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes
|
Rosenstock, J. |
|
2007 |
|
2 |
p. 175-185 |
artikel |
11 |
Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy
|
Garber, A. |
|
2006 |
|
2 |
p. 156-163 |
artikel |
12 |
News and Views
|
Holt, Richard I. G. |
|
2006 |
|
2 |
p. 234-236 |
artikel |
13 |
News and Views
|
Holt, Richard I. G. |
|
2007 |
|
2 |
p. 206-208 |
artikel |
14 |
Opportunities for gene therapy in preventing vein graft failure after coronary artery bypass surgery
|
Baker, Andrew H. |
|
2006 |
|
2 |
p. 119-124 |
artikel |
15 |
Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients
|
Finer, N. |
|
2006 |
|
2 |
p. 206-213 |
artikel |
16 |
Protein kinase B/Akt signalling is required for palmitate-induced β-cell lipotoxicity
|
Higa, M. |
|
2006 |
|
2 |
p. 228-233 |
artikel |
17 |
Reactive species and early manifestation of insulin resistance in type 2 diabetes
|
Fridlyand, L. E. |
|
2006 |
|
2 |
p. 136-145 |
artikel |
18 |
Subnormal energy expenditure: a putative causal factor in the weight gain induced by treatment of hyperthyroidism
|
Jacobsen, R. |
|
2006 |
|
2 |
p. 220-227 |
artikel |
19 |
The serum levels of proinsulin and their relationship with IGFBP-1 in obese children
|
Kamoda, T. |
|
2006 |
|
2 |
p. 192-196 |
artikel |
20 |
Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats
|
Kim, H. J. |
|
2006 |
|
2 |
p. 175-183 |
artikel |
21 |
Use of packaged entrees as part of a weight-loss diet in overweight men: an 8-week randomized clinical trial
|
Hannum, S. M. |
|
2006 |
|
2 |
p. 146-155 |
artikel |
22 |
Vildagliptin in combination with pioglitazone improves glycaemic control in patients with type 2 diabetes failing thiazolidinedione monotherapy: a randomized, placebo-controlled study *
|
Garber, A. J. |
|
2007 |
|
2 |
p. 166-174 |
artikel |